In mice, mothers with metabolic syndrome can ‘turn on’ offspring’s liver disease
New research from North Carolina State University has found that an imprinted gene associated with development of non-alcoholic fatty liver ...
Tag: turn
‘Fitbit for the face’ can turn any face mask into smart monitoring device
Northwestern University engineers have developed a new smart sensor platform for face masks that they are calling a “Fitbit for ...
Researchers use electron microscope to turn nanotube into tiny transistor
An international team of researchers have used a unique tool inserted into an electron microscope to create a transistor that’s ...
Imagining future guilt helps athletes turn away from doping – study
Appealing to athletes’ sense of ‘future guilt’ through psychological intervention could prove a powerful weapon in the fight against doping, ...
Stanford researchers reveal how to turn a global warming liability into a profitable food security solution
Like a mirage on the horizon, an innovative process for converting a potent greenhouse gas into a food security solution ...
Can defects turn inert materials into useful, active ones?
Demonstrating that a material thought to be always chemically inert, hexagonal boron nitride (hBN), can be turned chemically active holds ...
Ludwig Lausanne study shows how tumors turn immune cells into enablers of their growth
OCTOBER 25, 2021, NEW YORK – A Ludwig Cancer Research study has identified a means by which cancer cells engineer the ...
Right program could turn immune cells into cancer killers
FOR IMMEDIATE RELEASECredit: PNAS Dec. 10, 2002, Copyright (2002) National Academy of Sciences, U.S.A. FOR IMMEDIATE RELEASE Cancer-fighting immune cells ...
-
Multiple sclerosis more prevalent in Black Americans than previously thought
-
Nearly 70% of private label avocado oil rancid or mixed with other oils
-
Whales not to be counted on as ‘climate savers’: study
-
University of Sydney launches innovative research fellowship scheme to tackle global challenges
-
Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy
-
Null results research now published by major behavioral medicine journal